• SENSEX 82,633.66
    578.55 (+0.71%)
  • BANKNIFTY 56,461.90
    402.55 (+0.72%)
  • Garden Reach Sh.
    3,034.00 1,180.10(%)
  • Enviro Infra
    251.85 392.00(%)
  • Multi Comm. Exc.
    8,808.85 8,357.25(%)
  • Waaree Energies
    3,097.15 3,740.75(%)
  • Welspun Living
    142.00 213.10(%)
  • Vodafone Idea
    7.19 19.15(%)
  • M T N L
    57.90 101.88(%)
  • Bharat Electron
    409.30 240.15(%)
  • Cochin Shipyard
    2,120.50 1,180.45(%)
  • Netwrk.18 Media
    61.82 106.01(%)
  • Mazagon Dock
    3,224.45 1,917.95(%)
  • Hind.Aeronautics
    4,800.00 3,045.95(%)
  • Hyundai Motor I
    2,145.00 2,083.60(%)
  • Sammaan Capital
    143.85 179.35(%)
  • BEML Ltd
    4,422.00 2,346.35(%)
  • Dixon Technolog.
    14,090.00 10,613.00(%)
  • Vishal Mega Mart
    137.80 134.50(%)
  • Tata Motors
    678.80 1,179.05(%)
  • Data Pattern
    2,805.00 1,350.50(%)
  • Suzlon Energy
    63.93 46.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biocon Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 14801.0
  • ISIN : INE376G01013
349.20 -3 (-0.85%)
  • As on 25 Jun 2025 (EOD)
  • Today’s Low

    345.65
  • Today’s High

    351.50
  • Open

    350.00
  • Perv Close

    352.20
  • 52W Low

    291.00
  • 52W High

    404.70

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    46,686.77

  • Div & Yield %

    0.32

  • Book Value(₹)

    119.85

  • Debt-Equity Ratio

    -0.85

  • AGM Date

    24-Jun-2025

  • EPS

    0.37

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    46,686.77

  • RONW (%)

    6.89

  • ROCE (%)

    6.35

Score Board

  • Equity (₹ in Cr.)

    668.48

  • BV (₹)

    119.80

  • Sales( ₹ in Cr.)

    2,242.60

  • NP (in Cr.)

    49.23

  • NP Var(%)

    -54.0

  • Div%

    25.0

  • CPS (₹)

    1.30

  • EPS (₹)

    0.40

  • Traded Value (₹ in Lakhs)

    46,646.66

  • 52 Week High

    404.70

  • 52 Week Low

    291.00

  • Price BSE

    349.0

  • Price NSE

    349.00

  • Market Capital( in Cr.)

    46,646.66

  • P/C Ratio

    263.60

  • P/E Ratio

    947.80

  • Price Vs.BV

    0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2,127.30 1,992.90 1,738.20 2,028.40 1,988.40 1,785.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,127.30 1,992.90 1,738.20 2,028.40 1,988.40 1,785.70
Other Income 207.50 3,134.20 187.20 150.20 366.00 422.00
Stock Adjustments 99.10 -3.20 105.80 -36.70 31.40 69.10
Total Income 2,433.90 5,123.90 2,031.20 2,141.90 2,385.80 2,276.80
EXPENDITURE :            
Raw Materials 1,033.80 981.00 914.00 761.60 859.10 857.60
Power and Fuel Cost 215.30 279.20 231.00 186.00 193.30 152.40
Employee Cost 452.30 433.80 367.70 390.20 344.80 289.10
Other Manufacturing Expenses 155.40 127.10 130.50 147.00 118.30 104.30
Selling and Administration Expenses 135.00 112.20 106.70 128.40 208.40 222.40
Miscellaneous Expenses -28.10 32.90 33.00 66.00 9.90 18.70
Employee Benefit Expenses 452.30 433.80 367.70 390.20 344.80 289.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,963.70 1,966.20 1,782.90 1,679.20 1,733.80 1,644.50
Operating Profit 470.20 3,157.70 248.30 462.70 652.00 632.30
Interest 198.80 69.60 0.40 0.40 1.20 2.60
Gross Profit 271.40 3,088.10 247.90 462.30 650.80 629.70
Depreciation 121.10 116.90 108.20 103.50 98.00 92.30
Profit Before Tax 150.30 2,971.20 139.70 358.80 552.80 537.40
Current Tax 15.10 132.70 60.70 73.50 104.40 54.60
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 15.90 -9.90 -7.10 4.80 7.50 -9.90
Reported Net Profit 119.30 2,848.40 86.10 280.50 440.90 492.70
Extraordinary Items 13.41 2,861.73 2.92 3.00 136.27 166.64
Adjusted Net Profit 105.89 -13.33 83.18 277.50 304.63 326.06
Adjustment below Net Profit 30.70 29.40 -59.40 30.40 22.60 -51.80
P & L Balance brought forward 9,950.60 7,132.80 7,106.10 6,795.20 6,391.80 6,020.60
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 180.10 60.00 0.00 0.00 60.10 69.40
P & L Balance carried down 9,920.50 9,950.60 7,132.80 7,106.10 6,795.20 6,392.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 30.00 10.00 0.00 0.00 20.00
Dividend Per Share(Rs) 0.50 1.50 0.50 0.00 0.00 1.00
Earnings Per Share-Unit Curr 0.99 23.72 0.72 2.34 3.67 8.21
Earnings Per Share(Adj)-Unit Curr 0.99 23.72 0.72 2.34 3.67 4.11
Book Value 90.88 90.91 67.40 65.88 62.80 118.58
Book Value(Adj)-Unit Curr 90.88 90.91 67.40 65.88 62.80 59.29

Shareholding Pattern

  • Promoter Group

    54.45%

  • Public Share Holding

    45.37%

  • Custodian

    0.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 237,211,164 17.74 237,211,164 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 6,231,042 6,231,042.00 6,231,042 6,231,042
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 243,442,206 18.21 243,442,206 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 484,581,970 36.25 484,581,970 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 484,581,970 36.25 484,581,970 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,200 0.00 1,200 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 93,642,239 7.00 93,642,239 296
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 75,990,580 5.68 75,990,580 16
Mutual Funds / UTI 184,709,606 13.82 184,709,606 30
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 26,124,645 1.95 26,124,645 28
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 380,468,270 28.46 380,468,270 371
2] Non Institution
Bodies Corporate 18,381,379 1.37 18,381,379 1,699
Clearing Members 33,758 0.00 33,758 12
Directors of their Relatives 7,320,441 0.55 7,320,441 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 13,263,652 0.99 12,911,142 9,195
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 5,302,748 0.40 5,302,568 6,783
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 76,164,566 5.70 76,069,586 279
Individuals holding nominal share capital up to Rs. 1 lakh 98,773,609 7.39 98,764,327 411,851
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,025,726 0.08 1,025,726 15
Others 5,796,017 0.43 5,796,017 4
Sub Total 226,061,896 16.91 225,604,944 429,841
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 2,409,293 0.18 2,409,293 1
Total Shares held by Custodians and against which Depository Receipts have been issued 2,409,293 0.18 2,409,293 1
Grand Total ( A + B + C ) 1,336,963,635 100.00 1,336,506,683 430,217

Company Background

Biocon LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Biocon Ltd
  • BSE Code : 14801.0
  • ISIN : INE376G01013
  • Incorporation Year

    1978

  • Registered Office

    20th KM Hosur Road Hebbagodi
    Electronic City P O, Bangalore,
    Karnataka-560100

  • Telephone

    91-80-28082808

  • FAX

    91-80-28523423

  • Chairman

    Kiran Mazumdar Shaw

  • Managing Director

    SIDDHARTH MITTAL

  • Company Secretary

    Mayank Verma

  • Auditor

    BSR & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Biocon Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biocon 348.90 2,320.30 2,127.30 76.51 2.61
Abbott India 31,510.65 6,097.18 5,848.91 47.34 44.71
Astrazeneca Phar 8,798.50 1,330.33 1,295.53 190.03 33.26
P & G Health Ltd 5,912.35 1,166.89 1,151.26 39.07 39.76
Glaxosmi. Pharma 3,227.35 3,866.05 3,723.49 59.49 58.72
Cipla 1,502.85 20,029.57 19,044.85 23.53 21.40
Amrutanjan Healt 720.20 437.58 421.23 40.97 20.84
Guj. Themis Bio. 331.75 174.19 169.82 74.05 44.82
Fermenta Biotec. 305.00 315.24 307.09 13.28 4.10
Bliss GVS Pharma 148.60 638.96 605.46 22.69 11.19
Ambalal Sarabhai 35.73 11.70 3.81 33.08 1.92